The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.
Technology Summary This technology is a vacuum helmet that prevents the spread of patient aerosols during medical examinations and procedures while maintaining easy access to the patient’s nose and mouth.... Read More
Technology Summary This technology describes neutralizing antibodies sourced from dromedary camels that are effective against SARS-CoV-2 and related coronaviruses. Technology Overview COVID-19, caused by the SARS-CoV-2 virus, is an... Read More
Invention Summary Drug candidates to treat COVID-19 and a high throughput drug screening platform. Technology Overview The current COVID-19 pandemic has affected over 6 million people worldwide, has resulted in... Read More
Invention Summary Novel drug use and drug screening system for SARS-CoV-2 therapies. Technology Overview The outbreak of coronavirus disease COVID-19 caused by the novel SARS-CoV-2 virus has wreaked havoc... Read More
Invention Summary A platform of anti-inflammatory polymeric biomaterials that provides tunable immune responses via the modulation of macrophage metabolism. Technology Overview Macrophages (a type of white blood cell) produce... Read More
Invention Summary Nucleic acid amplification techniques are commonly used to diagnose viral diseases and determine when those who are sick remain capable of shedding/transmitting the virus. However, currently available methods... Read More
Cornell University is dedicated to bringing the University’s scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit. In these unprecedented times, the immediate need for innovation... Read More